Literature DB >> 17497286

Construction and identification of human tissue kallikrein gene eukaryotic expressing vector.

Yong Dai1, Wujian Peng, Tiyuan Li, Hong Du, Wenxue Sun, Deheng Chen, Zhuojia Xu.   

Abstract

To clone and sequence the human tissue kallikrein gene of Chinese, and to construct eukaryotic expression recombinant of KK, total RNA was extracted from human pancreas and human tissue kallikrein gene cDNA was amplified by PCR after reverse-transcription by using Oligo(dT) primer. The original kallikrein cDNA was recovered and filled with Klenow enzyme and inserted into KS plasmid. After restriction endonuclease digestion, KK cDNA was sequenced by ABI377 analyzer. Then the KK gene was amplified from pBluescript KSKK and inserted into pcDNA3. A sequence comparison showed that the cloned kallikrein gene was only one nucleotide different from that reported in the Genbank. The coding amino acid was Asp in the Genbank gene, while the coding amino acid of Chinese kallikrein gene was Asn. The KK cDNA fragment was inserted into the eukaryotic expression vector pcDNA3. The cloned kallikrein gene and the pcDNA3KK can be used for further study in gene therapy.. .

Entities:  

Mesh:

Substances:

Year:  2007        PMID: 17497286     DOI: 10.1007/s11596-007-0214-y

Source DB:  PubMed          Journal:  J Huazhong Univ Sci Technolog Med Sci        ISSN: 1672-0733


  7 in total

Review 1.  The new human tissue kallikrein gene family: structure, function, and association to disease.

Authors:  G M Yousef; E P Diamandis
Journal:  Endocr Rev       Date:  2001-04       Impact factor: 19.871

2.  Rescue of impaired angiogenesis in spontaneously hypertensive rats by intramuscular human tissue kallikrein gene transfer.

Authors:  C Emanueli; M B Salis; T Stacca; L Gaspa; J Chao; L Chao; A Piana; P Madeddu
Journal:  Hypertension       Date:  2001-07       Impact factor: 10.190

3.  Human tissue kallikrein gene delivery attenuates hypertension, renal injury, and cardiac remodeling in chronic renal failure.

Authors:  W C Wolf; H Yoshida; J Agata; L Chao; J Chao
Journal:  Kidney Int       Date:  2000-08       Impact factor: 10.612

Review 4.  Kallikrein and kinin receptor genes.

Authors:  R Mahabeer; K D Bhoola
Journal:  Pharmacol Ther       Date:  2000-10       Impact factor: 12.310

5.  Tissue kallikrein attenuates salt-induced renal fibrosis by inhibition of oxidative stress.

Authors:  Jenny J Zhang; Grant Bledsoe; Kazuo Kato; Lee Chao; Julie Chao
Journal:  Kidney Int       Date:  2004-08       Impact factor: 10.612

6.  Recombinant adeno-associated virus-mediated kallikrein gene therapy reduces hypertension and attenuates its cardiovascular injuries.

Authors:  T Wang; H Li; C Zhao; C Chen; J Li; J Chao; L Chao; X Xiao; D W Wang
Journal:  Gene Ther       Date:  2004-09       Impact factor: 5.250

Review 7.  An overview of the kallikrein gene families in humans and other species: emerging candidate tumour markers.

Authors:  George M Yousef; Eleftherios P Diamandis
Journal:  Clin Biochem       Date:  2003-09       Impact factor: 3.281

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.